San Francisco, March 10, 2016 -- According to a new report by Grand View Research, the global electrophysiology devices market is projected to reach $6.18 billion by 2020 with a CAGR of 5%. Growing occurrence of cardiac arrhythmias and elderly population base are the key market drivers. The global market has witnessed a huge rise in the usage rates of the electrophysiology devices in the recent years, with physicians increasingly getting experience in diagnostics & ablation techniques. The advent of technological advancements, like nanostim leadless pacemaker development, is also projected to boost the device usage rates.
Diagnostic electrophysiology catheters are projected to grow at the rate of 15% in the forecast period (2014–2020). Fast-paced growth witnessed in this segment, mainly because catheter ablation has become the first line of treatment for various rhythm disorders due to its ability to render success rates of about 95 percent.
Browse to access In-depth research report on Global Electrophysiology Devices Market with detailed charts and figures: http://www.grandviewresearch.com/industry-analysis/electrophysiology-devices-market
Electrophysiology monitoring devices & electrophysiology treatment devices are the two application sectors analyzed in this report. Electrophysiology monitoring devices accounted for about 60% of the total share in 2013. X-ray systems came up as the topmost electrophysiology monitoring sector in 2013. Increased portable & digital systems usage, improving interventional & diagnostic abilities of healthcare practitioners, is one of the major market growth drivers. The electrophysiology treatment devices sector includes pacemakers, implantable cardioverter defibrillators (ICD), & catheters. In 2013, catheters came up as the biggest treatment devices sub-segment. Widespread usage of treatment devices in electrophysiology studies & increasing interventional procedures’ volume are some of the key factors accounting for the segment’s biggest share.
Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/electrophysiology-devices-market/request
In 2013, North America was the biggest regional market accounting for over 30% of the total share. Increased awareness levels amongst patients and sophisticated healthcare infrastructure supporting large interventional procedures volumes are some of the major aspects accounting for the region’s large share. On the other hand, Asia-Pacific is projected to witness huge growth opportunities, mainly because of the great prevalence of patients with highly unmet medical requirements. Moreover, increase expenditure levels & rapidly developing healthcare infrastructure in the rising markets of China & India are providing great opportunities for the companies to capitalize on in the forecast period.
Some of the major electrophysiology devices manufacturers are Medtronic Inc., Abbott Laboratories, St. Jude Medical, Biotronik SE & Co. KG, and Boston Scientific Corporation.
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-electrophysiology-devices-market
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
email: [email protected]
Web: www.grandviewresearch.com


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 



